Showing results (2151-2160 of 2,197) with videos related to

Sort By:
Pageof 220
JAMA Network Open|August 15, 2022
Virologic Efficacy of Casirivimab and Imdevimab COVID-19 Antibody Combination in Outpatients With SARS-CoV-2 Infection: A Phase 2 Dose-Ranging Randomized Clinical TrialCynthia Portal-Celhay, Eduardo Forleo-Neto, Will Eagan, et al.
Nature Communications|April 14, 2026
Plasma phosphorylated tau 217 and longitudinal trajectories of Aβ, tau, and cognition in cognitively unimpaired older adultsHyun-Sik Yang, Juliana A U Anzai, Wai-Ying Wendy Yau, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 16, 2024
Patterns of recurrence after radiotherapy for high-risk neuroblastoma: Implications for radiation dose and fieldKevin X Liu, Sherif G Shaaban, Jie Jane Chen, et al.
Biochemical and Biophysical Research Communications|July 5, 2015
IL-15 induces strong but short-lived tumor-infiltrating CD8 T cell responses through the regulation of Tim-3 in breast cancerElise K Heon, Hasi Wulan, Loch P Macdonald, et al.
Cancer Cell|August 15, 2018
Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in Hürthle Cell CarcinomaRaj K Gopal, Kirsten Kübler, Sarah E Calvo, et al.
International Journal of Radiation Oncology, Biology, Physics|December 25, 2016
Multi-Institutional Experience of Stereotactic Ablative Radiation Therapy for Stage I Small Cell Lung CancerVivek Verma, Charles B Simone, Pamela K Allen, et al.
JAMA Neurology|February 2, 2026
Plasma Phosphorylated Tau 217 Cutoffs for Amyloid Pathology and Kidney Function, Body Mass Index, and AnemiaJihwan Yun, Jungah Lee, Daeun Shin, et al.
The Journal of Infectious Diseases|July 27, 2022
Casirivimab and Imdevimab for the Treatment of Hospitalized Patients With COVID-19Selin Somersan-Karakaya, Eleftherios Mylonakis, Vidya P Menon, et al.
The Lancet. Infectious Diseases|July 8, 2022
Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trialGary A Herman, Meagan P O'Brien, Eduardo Forleo-Neto, et al.
Journal of Neuro-Oncology|August 23, 2017
Prediction of new brain metastases after radiosurgery: validation and analysis of performance of a multi-institutional nomogramDiandra N Ayala-Peacock, Albert Attia, Steve E Braunstein, et al.
Pageof 220